Objective: Primary microcephaly (MCPH) is a rare autosomal recessive disorder characterized by impaired congenital reduction of brain size along with head circumference and intellectual disability. MCPH is a heterogeneous disorder and more than twenty four genes associated with this disease have been identified so far. The objective of this study was to find out the novel genes or mutations leading to the genetic defect in a Saudi family with primary microcephaly. Methods: Whole exome sequencing was carried out to find the novel mutation and the results was further validated using Sanger sequencing analysis. This study was done in the Center of excellence in Genomic Medicine and Research, King Abdulaziz University under KACST project during 2017 and 2018. Results: We report a novel compound heterozygous mutations c.797C>T in exon 7 and c.1102G>A in exon 9 of the WD repeat domain 62 (WDR62) (OMIM 604317) gene in two affected siblings in Saudi family with intellectual disability, speech impediments walking difficulty along with primary microcephaly. Two rare, missense variants were detected in heterozygous state in the WDR62 gene in these two affected individuals from the heterozygous parents. Conclusions: A compound heterozygous mutations c.797C>T in exon 7 and c.1102G> A in exon 9 of the WDR62 gene was identified. WDR62 gene is very important gene and mutation can lead to neuro developmental defects, brain malformations, reduced brain and head size. These results should be taken into consideration during prognostic discussions and mutation spectrum with affected patients and their families in the Saudi population.
INTRODUCTION
The autosomal recessive form of primary microcephaly (MCPH) is a rare genetic disorder that is characterized by head circumference less than three standard deviation below the mean from age and sex associated with mild to severe intellectual disability. 1 Twenty four genes MCPH1-MCPH24 have been reported so far those may be involved in the underlying cause of autosomal recessive primary microcephaly. However, Most of the mutations have been reported in two abnormal
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Novel compound heterozygous mutations in WDR62 gene leading to developmental delay and Primary Microcephaly in Saudi Family spindle microtubule assembly (ASPM) OMIM 608716 genes accounting for more than half of all mutations; and WDR62 gene around 10% of all reported cases related to primary microcephaly. 2 WD repeat domain 62 genes (WDR62 -GenBank Accession NM_005682.5) are known to play important role in cerebral cortical development and any mutations in this gene lead to cortical malformations, mental retardation and primary microcephaly. Recently a compound heterozygous mutations c.731 C > T (p.Ser 244 Leu) and c.2413 G > T (p.Glu 805 X) in the WDR62 gene responsible for the mitotic centrosomal protein WDR62, in a microcephaly family from Japanese. 3 We have also reported in our recent study a missense mutation in exon 30 of WDR62changing alanine to aspartate in the protein leading to the typical MCPH2 phenotype. 4 Whereas new homozygous splicing variantc.3335+1G>C in the WDR62 gene also reported recently. 5 Previously pathogenic mutations reported in WDR62 include missense (e.g. W224S; E526K; R438H) and truncating mutations (e.g. Q470X; Val1402GlyfsTer12; 2083delA; 2472_2473delAG; Gly1280AlafsTer21; c.2527dupG; p.R438H; c.390G>A; p.D955Afs*112). [6] [7] [8] [9] [10] [11] [12] In this study two rare, missense variants were detected as compound heterozygous state in the WDR62 gene of these patients results as c.797C>T, exon 7 (Ala266Val) and c.1102G>A, exon 9 (Asp368Asn) and these mutation leading to the typical MCPH2 MIM 604317 phenotype in Saudi family. The human genome contains two copies of each gene, a paternal and a maternal allele. A mutation affecting only one allele is called heterozygous and affecting both allele called compound heterozygous mutation and if we find any mutation affecting both allele may lead to the disease phenotype. Interestingly, both variants are predicted to be deleterious by the majority of in silico prediction tools and are rare in the general population.
METHODS

Sample Collections:
The detailed pedigree (family chart) was drawn after obtaining all the available information from the family as shown in (Fig.1) . Detailed written informed consent was taken from all family members and parents before the extraction of blood. This study was approved by the ethical committee of the Center of Excellence in Genomic Medicine Research, King Abdulaziz University Jeddah. The blood samples were collected in the EDTA tube from father, mother and two affected girls. The affected members were under medical examination at Taif Hospital, Saudi Arabia. Patient 1 (IV-1): Patient 1 (IV-1) was 11 years old girl at the time of examination and blood In silico analysis and functional prediction of these mutations were analyzed using the available online prediction software tolls that includes, Mutation Taster, PolyPhen-2 (http://genetics.bwh.harvard. edu/pph2/) PROVEAN/SIFT (http://provean. jcvi.org/) and PhastCons (http://compgen.cshl. edu/phast/) etc.
RESULTS
Compound Heterozygous Mutations in WDR62
Identified through Exome Sequencing: Whole exome sequencing revealed two rare, missense variants detected in heterozygous state in the WDR62 gene of this patient. The compound heterozygous missense mutations were in exon 7 and 9 of WDR62 gene in both affected individuals where c.797C>T, p.(Ala266Val) and c.1102G>A, p.(Asp368Asn).Two rare, missense variants were detected in compound heterozygous state in the WDR62 gene of two affected patient with primary microcephaly. DNA analysis of parents and affected family members was used to verify cosegregation of the identified variants with the phenotype and establish a compound heterozygous state of these variants. Segregation analysis was done to determine whether these variants are present in compound heterozygous state. Our results showed a compound heterozygous mutation in WDR62gene in exon 7 and 9 in the two affected girls. All the mutation for WDR62 gene known so far is represented in Table-I . Sanger sequencing: Our Sanger sequencing results showed a compound heterozygous mutation in MCPH1 gene where at 982 (c.982G>A) and at position 1273 (c.1273T>A) in exon 8 of the both affected IV-1, and IV-2 proband whereas the one parent was heterozygous at one position while other was heterozygous at other position as shown in (Fig.2) . The found mutation was further validated in 100 control samples, but no one has this sequence Naseer et al. variation. Both the parents of the affected members were heterozygous at different positions, which also confirm the compound heterozygosity in this family. In silico Analysis: The detailed bioinformatics and functional prediction of identified mutations for deleterious effects were completed using the online In silico prediction software package PROVEAN/SIFT, PolyPhen-2, and PhastCons as mentioned in Table- II. Furthermore, in the Greater Middle East (GME) minor allele frequency Table- II.
DISCUSSION
WDR62 encodes a protein which is required for cerebral cortical development and neurogenesis. 13 It is proposed to play a role in neuronal migration and proliferation. 7, 14 The Wdr62 expression was found to developing mouse brain, with maximum expression in the forebrain.
14 Wdr62 gene genetically interacts with Aurora A to regulate mitotic progression, spindle formation and maintaining the size of brain. Whereas loss of these gene interactions leads to delay in mitosis and cell death of neural progenitor cells (NPCs) which may cause of human primary microcephaly. 15 Mutations in WDR62 have been associated with primary microcephaly 2 (MCPH2), with or without cortical malformations. 14, 16, 17 This is a disease characterized by microcephaly associated with other manifestation and showing a wide phenotypic variability.
18 Associated features include modest to severe mental retardation, and numerous type of cortical malformations in patients with primary microcephaly. Cortical malformations may include cortical thickening, pachygyria lissencephaly, microgyria, schizencephalyhypoplasia of the corpus callosum. Most of the affected individuals have delayed psychomotor development and having seizures in many cases. Based on the referral note for this patient, mutations in WDR62 could be of relevance for the reported microcephaly. Additional clinical evaluation and investigations (EEG, MRI) are needed to determine the relevance of this variant. The here detected variants cause two alterations of conserved residues (p.Asp368Asn and p.Ala288Val). p.Asp368Asn alters a residue within the WD5 domain, whereas p.Ala288Val is located in between WD3 and WD4. The main function of all WD-repeat proteins is to coordinate multi-protein complex assemblies, whereas for the protein interactions these repeating units serve as a rigid scaffold. Both detected mutations have not been previously reported.
CONCLUSION
We have identified a novel compound heterozygous c.797C>T in exon 7 and c.1102G>A mutations in exon 9 of the WDR62 gene in two affected siblings of Saudi family with intellectual disability, speech impediments walking difficulty and primary microcephaly. We suggest that these type of studies are required to identify complete mutation spectrum related to primary microcephaly which will be useful for the precise clinical diagnosis of individuals suffering from disease in Saudi population.
